Lexeo Therapeutics Inc

LXEO NASDAQ Healthcare & Biotech United States US52886X1072
2.76 $
4.94 %

Lexeo Therapeutics focuses its efforts on the research and development of gene therapies for the treatment of genetic and neurodegenerative heart diseases.